ASSESSMENT OF PNEUMONIA MANAGENTOFUNDER- FIVE CHILDRENAT BOLE BULBULA HEALTH CENTER, ADDIS ABABA, ETHIOPIA, 2024

ASSESSMENT OF PNEUMONIA MANAGENTOFUNDER- FIVE CHILDRENAT BOLE BULBULA HEALTH CENTER, ADDIS ABABA, ETHIOPIA, 2024

Registration ID: IJNRD_219556

Published ID: IJNRD2405226

DOI: Click Here to Get

YALELET CHANIE MILASHU , GETAHUN SISAY , FREHIWOT ZERIHUN , KALEB KASTRO , REBIRA JISA,BIRHANU MEKONNEN

:-Adherence to management Drug Evaluation, Amoxicillin, pneumonia

Abstract Introduction: - Pneumonia remains the leading cause of child mortality resulting from infectious diseases worldwide. Particularly in Ethiopia, pneumonia continues to be the primary cause of death among children under the age of five. The high prevalence of pneumonia and its significant financial implications highlight the importance of accurate diagnosis and appropriate management of patients. It is crucial to diagnose pneumonia precisely and use antibiotics judiciously to address the growing crisis of antibiotic resistance. When initial antibiotics become ineffective due to microbial resistance, more expensive medications must be used. This leads to prolonged illness and treatment, often requiring hospitalization, which not only increases healthcare expenses but also imposes a substantial economic burden on families and societies. Numerous studies have shown that adherence to treatment guidelines can reduce morbidity, mortality, and healthcare costs. Guidelines play a critical role in directing and standardizing the management of pneumonia. However, there is evidence suggesting that national guidelines for pneumonia management are frequently disregarded in clinical practice. Objective: - To assess the extent of adherence to treatment guidelines in the management of pneumonia in under-5 OPD of Bole Bulbula health center, Addis Ababa, Ethiopia, From January 2023 to January 2024. Methodology: - The study involved the review of one hundred twenty charts of children under five at Bole Bulbula Health Center under 5 OPD as secondary data. Children's card numbers were selected using systematic random sampling from the under-five outpatient department and sent to the card room to retrieve individual folders. Data were collected directly from the individual folders using a structured questionnaire prepared by Kobo Toolbox for data collection. Results: - The majority of the children (56, 46.7%) received treatment for pneumonia with Amoxicillin suspension, while another group of children (50, 41.7%) were treated with Amoxicillin dispersible tablets. A small number of children (3, 2.5%) were treated with Azithromycin syrup, and the remaining children (11, 9.2%) received other medications. All of the children (56, 100%) were managed with the standard dose of Amoxicillin suspension (30-50mg/kg), and all 50 (100%) children received the standard dose of amoxicillin dispersible tablets. All of children (106, 100%) were given Amoxicillin Dispersible tablet or suspension for 5-7 days, and there were no contraindications for this medication among any of the children. Additionally, there were no reported drug interactions with Amoxicillin suspension. The full names, qualifications, signatures, and dates of the prescribers were documented in the individual folders of 84 (70%), 63 (52.5%), 117 (97.5%), and 114 (95%) children, respectively. Out of these, sixty-six (55%) were male and fifty-four (45%) were female. The average age of the individuals was 1.33 years (95% CI: 0.1-2.59). Their average weight was 8.3 kilograms (95% CI: -4.5-18).None of the children's length, their head circumference and MUAC were not measured. Conclusion: The utilization of the first-line drug amoxicillin dispersible tablet at Bole Bulbula Health Center was found to be inadequate. However, the treatment approach for managing pneumonia in children under 5 years old at the OPD of BBHC through first line, 2nd line and alternative drug was relatively satisfactory. The Duration Of treatment for under five children’s treated with the recommended drugs duration were appropriate.

Published Paper   E-Certificate

"ASSESSMENT OF PNEUMONIA MANAGENTOFUNDER- FIVE CHILDRENAT BOLE BULBULA HEALTH CENTER, ADDIS ABABA, ETHIOPIA, 2024", IJNRD - INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (www.IJNRD.org), ISSN:2456-4184, Vol.9, Issue 5, page no.c222-c232, May-2024, Available :https://ijnrd.org/papers/IJNRD2405226.pdf

Volume 9 Issue 5, May-2024

Pages : c222-c232

Paper Reg. ID: IJNRD_219556

Published Paper Id: IJNRD2405226

Downloads: 000121175

Research Area: Pharmacy

Country: Addis Ababa , Addis Ababa , Ethiopia

Published Paper PDF: https://ijnrd.org/papers/IJNRD2405226.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2405226

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 8 | August 2025

IJNRD is Scholarly open access journals, Peer-reviewed, and Refereed Journals, High Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) with Open-Access Publications.

INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world. IJNRD will provide an opportunity for practitioners and educators of engineering field to exchange research evidence, models of best practice and innovative ideas.

Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: August 2025

Current Issue: Volume 10 | Issue 8

Last Date for Paper Submission: Till 31-Aug-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: International Peer-reviewed, Refereed, and Open Access Journal.

Subject Category: Research Area